↓ Skip to main content

Circulating tumor cells as a prognostic marker for efficacy in the randomized phase III JO21095 trial in Japanese patients with HER2-negative metastatic breast cancer

Overview of attention for article published in Breast Cancer Research and Treatment, February 2017
Altmetric Badge

Mentioned by

twitter
2 X users

Citations

dimensions_citation
13 Dimensions

Readers on

mendeley
47 Mendeley